34 results on '"Forconi, Francesco"'
Search Results
2. The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia
3. The outcome of Chronic lymphocytic leukaemia patients with 97%IGHVgene identity to germline is distinct from cases with <97% identity and similar to those with 98% identity
4. Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ fromde novodiffuse large B-cell lymphoma
5. Genome‐wide high resolution DNA profiling of hairy cell leukaemia
6. Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone
7. Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome
8. Integrated DNA copy number and methylation profiling of lymphoid neoplasms using a single array
9. The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: A retrospective multicentric GIMEMA experience
10. Molecular history of Richter syndrome: origin from a cell already present at the time of chronic lymphocytic leukemia diagnosis
11. Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia
12. Del(13q14.3) length matters: an integrated analysis of genomic, fluorescence in situ hybridization and clinical data in 169 chronic lymphocytic leukaemia patients with 13q deletion alone or a normal karyotype
13. Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia
14. 13q14 Deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia
15. A pilot monocentric analysis of efficacy and safety of Fludarabine-Campath combination (Flucam) as first line treatment in elderly patients with chronic lymphocytic leukaemia and Tp53 disfunction
16. Lack of allelic exclusion by secondary rearrangements of tumour B-cell receptor light chains in hairy cell leukaemia
17. B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage
18. A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome
19. Hairy cell leukaemia: biological and clinical overview from immunogenetic insights
20. Immunogenetics features and genomic lesions in splenic marginal zone lymphoma
21. MDM4 (MDMX) is overexpressed in chronic lymphocytic leukaemia (CLL) and marks a subset of p53wild‐type CLL with a poor cytotoxic response to Nutlin‐3
22. IGHD3-3fails to behave as unfavourable prognostic marker in chronic lymphocytic leukaemia
23. Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas
24. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors
25. Long‐term follow‐up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis
26. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study
27. Low-dose oral fludarabine plus cyclophosphamide in elderly patients with untreated and relapsed or refractory chronic lymphocytic Leukaemia
28. Genome‐wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion
29. Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis
30. High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia
31. The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia
32. Incidence of novel N-glycosylation sites in the B-cell receptor of lymphomas associated with immunodeficiency
33. Insight into the potential for DNA idiotypic fusion vaccines designed for patients by analysing xenogeneic anti-idiotypic antibody responses
34. Mutation ofBAX occurs infrequently in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.